Clinical characteristics and therapeutic evaluation of childhood myasthenia gravis

Experimental and Therapeutic Medicine
Zhi-xiao YangHui Xiong

Abstract

This study aimed to analyze the clinical characteristics, classification and treatment of childhood myasthenia gravis (MG) and address the prognosis through follow-up. The clinical data of 135 children with MG were grouped according to clinical type and therapeutic drugs, retrospectively analyzed and prospectively monitored. Of the 135 MG patients, 85.2% had type I (ocular type), with only 4.2% progressing to systemic MG; 13.4% had type II (general type); and 1.5% had type III (fulminating type). Relapse occurred in 46.1% of the 102 patients that were followed up. The positive rate for the primary acetylcholine receptor antibody was 40.19%, without significant differences among clinical subtypes. The positive rate of the repetitive nerve stimulation frequency test by electromyography was 37.97%. Decreased expression of CD4(+), CD8(+), or CD3(+) was present in 71% of the patients. Thymic hyperplasia was present in 5.93% of the patients, while 1.48% had thymoma. Steroid treatment was effective in the majority of the patients. Ocular type MG was common in this cohort of patients. The incidence and mortality of myasthenia crisis were low, the presence of concurrent thymoma was rare and only a limited number of children developed ne...Continue Reading

References

Jan 12, 2001·Acta Neurologica Scandinavica·H YoshikawaM Yamada
Aug 11, 2001·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·L K TanwaniS P Mokshagundam
Mar 9, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Noriaki ShinomiyaMasaya Segawa
Feb 25, 2005·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·L PaduaP Tonali
Nov 8, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·Xiaofan ZhangAngela Vincent
Jun 1, 2007·Autoimmunity Reviews·Mario García-CarrascoRicard Cervera
Jun 24, 2008·Annals of the New York Academy of Sciences·Matthieu GiraudHenri-Jean Garchon
Apr 21, 2009·Lancet Neurology·Matthew N Meriggioli, Donald B Sanders
May 2, 2009·Journal of Child Neurology·Ildiko H KovesAndrew J Kornberg
Feb 5, 2010·Neuroepidemiology·Anita McGroganCorinne S de Vries
May 10, 2011·Neuropsychiatric Disease and Treatment·Renato MantegazzaCarlo Antozzi
May 11, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P J ChienC M Shih
Jun 4, 2011·Journal of Autoimmunity·Erdem TüzünPremkumar Christadoss
Feb 22, 2012·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Vasiliki ZouvelouIoannis Evdokimidis

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Zhi-xiao YangXi-ru Wu
Rinsho hoshasen. Clinical radiography
H IkedaT Kozuka
Canadian Medical Association Journal
D L A BASTEDO
© 2021 Meta ULC. All rights reserved